![](/img/cover-not-exists.png)
Pegylated (40kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study
Michael W. Fried, Mitchell L. Shiffman, Rejender K. Reddy, Coleman Smith, George Marino, Femando Goncales Jr, Dieter Haeussinger, Moises Diago, Giampietro Carosl, Jean-Pierre Zarski, Joseph Hoffman, JVolume:
120
Year:
2001
Language:
english
DOI:
10.1016/s0016-5085(08)80271-5
File:
PDF, 196 KB
english, 2001